Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

RenovoRx (RNXT) Return on Sales (2025)

RenovoRx (RNXT) has disclosed Return on Sales for 1 consecutive years, with 14.48% as the latest value for Q4 2025.

  • Quarterly Return on Sales changed N/A to 14.48% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 10.76% through Dec 2025, changed N/A year-over-year, with the annual reading at 10.76% for FY2025, 23543.0% up from the prior year.
  • Return on Sales hit 14.48% in Q4 2025 for RenovoRx, down from 11.61% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 6.03% in Q2 2025 to a low of 15.25% in Q1 2025.